MGARP and dysplasia: We then investigated whether the OSAP activation parallels disease progression by scoring the refined OSAP signature in a dataset (GSE37283) previously used to unveil differential gene expression in the remote, quiescent, non-dysplastic mucosa of patients harboring neoplastic lesions compared to the mucosa of UC patients without dysplasia and normal controls [24].